eli lilly tirzepatide news today FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight Management, a Powerful New Option for the Treatment of Obesity or Overweight with Weight-Related Medical Problems China Clears Eli Lilly's Weight

The babies in the research study developed normally with no reported problems

As per an article published by the Canadian Health Policy Journal in April 2026, the most-favored-nation (MFN) reference-specific drug pricing policy was launched by the government, demanding brand medicines without competitors to be set at the lowest pricing strategy, with a GDP per capita of nearly 60%

The peptide has been in investigational status since its synthesis at the University of Arizona in 1991, and that status has not changed in 2026

Rossi, M

So I was kinda on my own there

Ideal Candidates Tirzepatide may be appropriate for adults who struggle to achieve or maintain weight loss despite consistent lifestyle efforts